Health and Medical Guide to Diagnostic Tests CT Scans Health information topics about CT Scans: Children 1. Pediatric CT (Computed Tomography) Radiological Society of North America http://www.radiologyinfo.org/content/pedia-ct.htm Dictionaries/Glossaries 1. Radiology Info: Glossary of Terms American College of Radiology, Radiological Society of North America http://www.radiologyinfo.org/glossary/glossary1.cfm 2. Glossary of Imaging and Scanning Tests Nemours Foundation http://kidshealth.org/parent/system/medical/labtest12.html Directories 1. American College of Radiology Accredited Facilitie American College of Radiology http://apps2.acr.org/lib/afw/afw-search.php National Institutes of Health 1. Computed Tomography (CT): Questions and Answers National Cancer Institute http://cis.nci.nih.gov/fact/5_2.htm Organizations 1. Radiology Info American College of Radiology, Radiological Society of North America http://www.radiologyinfo.org/ 2. Center for Devices and Radiological Health http://www.fda.gov/cdrh/ Overviews 1. Computerized Tomography (CT, CT Scan, CAT Scan) Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=FL00065 2. What You Need to Know about Your Computed Tomograp Cleveland Clinic Foundation http://www.clevelandclinic.org/health/health-info/docs/1700/1731.asp?index=... Prevention/Screening 1. Whole Body Scanning Using Computed Tomography (CT) Center for Devices and Radiological Health http://www.fda.gov/cdrh/ct/ 2. Use of New Imaging Techniques to Screen for Corona American Heart Association http://circ.ahajournals.org/cgi/reprint/108/8/e50.pdf 3. Coronary Calcium Scans: Heart Scans Mired in Contr Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=HB00015 Research 1. Virtual Colonoscopy Not Ready for Routine Use American Cancer Society http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Virtual_Colonoscopy_Not_... 2. Spiral Scan Sees Stroke Blockage More Clearly American Heart Association http://www.americanheart.org/presenter.jhtml?identifier=3001835 3. Full-Body CT Scans: Too Much Radiation? American Cancer Society http://www.cancer.org/docroot/NWS/content/NWS_2_1x_Full-Body_CT_Scans_Too_M... Specific Conditions 1. Virtual Colonoscopy National Digestive Diseases Information Clearinghouse http://digestive.niddk.nih.gov/ddiseases/pubs/virtualcolonoscopy/index.htm 2. SPECT Scan (Single-Photon Emission Computerized To Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=AN00617 3. Glossary of Neurological Diagnostic Tests American Association of Neurological Surgeons http://www.neurosurgerytoday.org/what/patient_e/glossary.asp 4. Cancer Imaging National Cancer Institute http://imaging.cancer.gov/imaginginformation/ 5. Computed Tomography (CT): Abdomen Radiological Society of North America http://www.radiologyinfo.org/content/ct-abdomen.htm 6. Computed Tomography (CT): Body American College of Radiology, Radiological Society of North America http://www.radiologyinfo.org/content/ct_of_the_body.htm 7. Computed Tomography (CT): Chest Radiological Society of North America http://www.radiologyinfo.org/content/chestct.htm 8. Computed Tomography (CT): Head American College of Radiology, Radiological Society of North America http://www.radiologyinfo.org/content/ct_of_the_head.htm 9. Computed Tomography (CT): Spine Radiological Society of North America http://www.radiologyinfo.org/content/spinect.htm 10. Computed Tomography Angiography (CTA) American College of Radiology, Radiological Society of North America http://www.radiologyinfo.org/content/ct-angiography.htm 11. Computer Imaging / Tomography American Heart Association http://www.americanheart.org/presenter.jhtml?identifier=4554 12. Computed Tomography Scan and Magnetic Resonance Im American Heart Association http://circ.ahajournals.org/cgi/reprint/108/15/e104.pdf   Clinical Trials / Drug Trials News From Medical News Today Latest Health News and Medical News posted throughout the day, every day. Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia 5 Sep 2010 at 3:00am Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tablets will be registered in Australia under the trade name Movectro®... HeartWare Receives Second Patient Allotment Under Continued Access Protocol F... 4 Sep 2010 at 3:00am HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S... Optimer Pharmaceuticals Announces Presentations Of Additional Fidaxomicin Pha... 3 Sep 2010 at 6:00am Results from studies related to Optimer Pharmaceuticals, Inc.'s (Nasdaq: OPTR) lead developmental product candidate, fidaxomicin, will be presented at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) to be held at the Boston Convention and Exhibition Center in Boston on September 12-15, 2010... Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At Worl... 3 Sep 2010 at 4:00am Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced the final data set from its Phase 3 study of Ketotransdel® (TDLP-110) at the 13th World Congress on Pain in Montreal, Canada... Soligenix Announces Publication Of Article Identifying Domains Within The Ric... 3 Sep 2010 at 4:00am Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced the publication of an article online in Vaccine. The article describes the systematic identification of neutralizing and non-neutralizing B-cell epitopes on ricin toxin's enzymatic A subunit (RTA)... Inhibitex Successfully Completes Phase 1a Trial Of INX-189 3 Sep 2010 at 4:00am Inhibitex, Inc. (Nasdaq: INHX), announced that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo... Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspar... 3 Sep 2010 at 4:00am Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®... Eisai Announces The Start Of The First Clinical Study Of Ban2401, A Novel Mon... 2 Sep 2010 at 6:00am Eisai Co., Ltd. (Headquarters: Tokyo, Japan, President & CEO: Haruo Naito, "Eisai") announced today the start of the first patient enrolled clinical study with BAN2401, a novel monoclonal antibody that is being developed as a potential next-generation therapeutic treatment for Alzheimer's disease... Trial To Test Experimental Drug For Advanced Pancreatic Cancer 2 Sep 2010 at 6:00am Cancer Research UK's Drug Development Office has launched a clinical trial* to test an experimental drug in patients with advanced (Stage IV) pancreatic cancer - one of the most difficult cancers to treat. Around 60 patients with advanced pancreatic cancer will be recruited for the first Phase I/IIclinical trial of a drug called MK-0752** in this disease... Roche Provides Update On FDA Application For T-DM1 2 Sep 2010 at 5:00am Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned Roche will continue with its ongoing Phase III EMILIA registration study... QRxPharma Announces Interim Analysis Of Final Pivotal Phase 3 Study For MoxDu... 2 Sep 2010 at 4:00am QRxPharma (ASX: QRX and OTCQX: QRXPY) announced a successful interim analysis of its final MoxDuo IR pivotal Phase 3 study required for New Drug Application (NDA) submission. The analysis indicated the planned sample size of 140 patients has greater than 90% power to detect differences of analgesic effect, indicating there is no need to enrol additional patients... Agensys, An Affiliate Of Astellas, Announces Initiation Of Phase I Clinical T... 2 Sep 2010 at 4:00am Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing... Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results 2 Sep 2010 at 4:00am A recent study conducted by oculoplastic surgeon Charles Soparkar, M.D., Ph.D. (The Methodist Hospital, Houston, TX) utilizing a patent-pending formulation of zinc and phytase (trademarked as ZYTAZE™), demonstrated that increasing zinc levels by oral administration for 4 days prior to a planned injection of botulinum toxin improved efficacy and/or duration in 41 of 44 patients tested (93%)... ReVision's Fenretinide (RT-101) Reduced Incidence Of Choroidal Neovasculariza... 2 Sep 2010 at 4:00am ReVision Therapeutics Inc. announced that data from a Phase 2b trial show that fenretinide (RT-101) reduced the incidence of choroidal neovascularization (CNV, wet age related macular degeneration) by about 50 percent in patients with geographic atrophy (GA), the most advanced form of dry age related macular degeneration (AMD). The data, presented Monday by Alexander M. Eaton, M.D... Microplasmin Meets Primary Endpoint In Second Phase III Trial In VMA, Confirm... 2 Sep 2010 at 4:00am ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of vitreomacular adhesion (VMA) has met its primary endpoint...     HealthBusinessBuilder.com Build your Health Business Fast!